IMOS vs MSFT

Despite a strong Piotroski F-Score of 7/9 indicating solid operational health, IMOS is severely overvalued with a current price of $40.91 far exceeding its Graham Number ($14.41) and Intrinsic Value ($12.69). While the company shows impressive earnings growth (126.8% YoY), its profitability is precarious with a razor-thin profit margin of 2.07%. Most concerning is the unsustainable dividend payout ratio of 176.43%, suggesting the dividend is funded by capital or debt rather than earnings. The combination of a bearish technical trend (10/100) and extreme valuation multiples makes the current entry point high-risk.

Microsoft exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust financial stability. While the stock is currently experiencing a severe technical downtrend (0/100) and significant 6-month price depreciation (-28.6%), the current price of $374.33 sits well below the growth-based intrinsic value of $471.41 and the analyst target of $587.31. Exceptional earnings growth (59.8% YoY) and high operating margins (47.09%) suggest that the current price correction presents a value opportunity despite bearish insider sentiment.